About our Research Programs

The research programs of the Asthma/Allergy and Clinical Immunology Division include investigations in rhinitis, asthma, hypersensitivity pneumonitis, aspergillus mediated allergic diseases, food allergy, and primary immunodeficiencies.

Current research studies:

  1. Pediatric and Adult Asthma Trials:
    • Phase IIIb Multi-center, Randomized, Double¬-Blind, Placebo-¬Controlled Study of Xolair® in Subjects with Moderate to Severe Persistent Asthma Who are Inadequately Controlled With High-Dose Inhaled Corticosteroids and Long-Acting Beta-Agonist
    • Epidemiologic Study of Xolair® (Omalizumab): Evaluating Clinical Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma (EXCELS)
    • A 1 Year, Randomized, Double Blind, Parallel-Group, Placebo-Controlled, Multicenter Evaluation of Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Omalizumab in Children (6 - <12 years) With Moderate-Severe, Persistent, Inadequately Controlled Allergic Asthma.
    • Study of Acid Reflux in Children with Asthma (SARCA): The purpose of this NIH funded research is to test the hypothesis that children with symptomatic asthma will have improved asthma control with medical treatment of esophageal reflux with the proton-pump inhibitor, lansoprazole, as compared to children treated with placebo.
  2. Food Allergy: We have ongoing clinical research projects in the area of food allergies. Current studies include:
    • Detection of Peanut Protein in Serum and Saliva
    • Determination Of Minimum And Non-Provoking Doses Of Soy Protein In Soy Allergic Individuals
  3. Primary Immunodeficiency
    • Pilot Program to Screen Newborns for Severe Combined Immune Deficiency (SCID) in Wisconsin: The purpose of this research is to develop a collaborative program with the WI State Department of Hygiene to screen all newborns in the State of WI for SCID. We will extract DNA from blood spots on newborn screening cards and use real time PCR to quantitate T cell receptor circles to screen for SCID.
    • Lymphoproliferative Disorders in Primary Immunodeficiencies: the purpose of this research is to determine if transforming viral infections lead to lymphoproliferative disorders in patients with primary immune deficiencies.

Contact Us

Department of Pediatrics
Division of Asthma/Allergy and Clinical Immunology
9000 W. Wisconsin Ave., Suite B440
Milwaukee, WI 53226

Administration:
Phone: (414) 266-6840
Fax: (414) 266-6437

Clinic: (414) 266-6450

Allergy Fellow On Call: (414) 266-2000

Division Faculty & Staff

Asthma/Allergy and Clinical Immunology Site Map

Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, WI 53226
(414) 955-8296
Directions & Maps
© 2014

Page Updated 10/23/2014
Top